Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation - results from the Dresden NOAC registry

被引：0
|
作者：
Hecker, J. [1 ]
Marten, S. [1 ]
Tittl, L. [1 ]
Beyer-Westendorf, J. [1 ]
机构：
[1] Univ Hosp Dresden, Dresden, Germany
来源：
CEREBROVASCULAR DISEASES | 2016年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O101
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [31] Effectiveness and Safety of DOACs in Atrial Fibrillation Patients Undergoing Catheter Ablation: Results from the China Atrial Fibrillation (China-AF) Registry
    Dong, Zhimin
    Hou, Xiaoxia
    Du, Xin
    He, Liu
    Dong, Jianzeng
    Ma, Changsheng
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [32] Effectiveness and safety of rivaroxaban in a cohort of 142 patients with nonvalvular atrial fibrillation treated with rivaroxaban for the prevention of stroke
    Jose Cerezo-Manchado, Juan
    Navarro-Almenzar, Begona
    Elvira Ruiz, Gines
    Garcia-Candel, Faustino
    Flores Blanco, Pedro
    Caro-Martinez, Cesar
    Manzano-Fernandez, Sergio
    Garcia-Iniesta, Natalia
    Sanchez-Garcia, Javier
    Cabanas-Perianes, Valentin
    Moraleda Jimenez, Jose Maria
    FUTURE CARDIOLOGY, 2018, 14 (03) : 31 - 37
  • [33] Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry
    Beyer-Westendorf, J.
    Camm, A. J.
    Virdone, S.
    Fox, K. A. A.
    Pieper, K. S.
    Le Heuzey, J. -Y.
    Haas, S.
    Kayani, G.
    Gersh, B. J.
    Turpie, A. G. G.
    Kakkar, A. K.
    EUROPEAN HEART JOURNAL, 2021, 42 : 578 - 578
  • [34] Efficacy and safety of rivaroxaban in extreme elderly patients with atrial fibrillation: Analysis of the Shikoku Rivaroxaban Registry Trial (SRRT)
    Bando, Shigenobu
    Nishikado, Akiyoshi
    Hiura, Norikazu
    Ikeda, Shuntaro
    Kakutani, Akiyoshi
    Yamamoto, Katsuhito
    Kaname, Noriyoshi
    Fukatani, Masahiko
    Takagi, Yuichiro
    Yukiiri, Kazushi
    Fukuda, Yamato
    Nakaya, Yutaka
    JOURNAL OF CARDIOLOGY, 2018, 71 (1-2) : 197 - 201
  • [35] NOAC Therapy Is Also Effective and Safe in Patients Older Than 80 Years - Results of the Prospective Dresden NOAC Registry (NCT01588119)
    Beyer-Westendorf, Jan
    Tittl, Luise
    Naue, Christiane
    Marten, Sandra
    BLOOD, 2018, 132
  • [36] Czech AF 2012 registry: profile of atrial fibrillation patients receiving antithrombotic therapy before noac
    Spinar, J.
    Vitovec, J. V.
    Spinarova, L. S.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1102 - 1102
  • [37] Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
    Coleman, Craig, I
    Martinez, Brandon K.
    Bunz, Thomas J.
    Eriksson, Daniel
    Meinecke, Anna-Katharina
    Sood, Nitesh
    Baker, William L.
    CIRCULATION, 2018, 138
  • [38] Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
    Martinez, Brandon K.
    Baker, William L.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Meinecke, Anna-Katharina
    Eriksson, Daniel
    Coleman, Craig, I
    PHARMACOTHERAPY, 2019, 39 (02): : 196 - 203
  • [39] Effectiveness and safety of rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and heart failure
    Coleman, C. I.
    Baker, W. L.
    Bunz, T. J.
    Eriksson, D.
    Meinecke, A. K.
    Sood, N. A.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1012 - 1012
  • [40] Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care
    Gorst-Rasmussen, Anders
    Lip, Gregory Y. H.
    Larsen, Torben Bjerregaard
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (11) : 1236 - 1244
12345